Skip to main content
Lancet Regional Health - Americas logoLink to Lancet Regional Health - Americas
. 2024 Aug 3;37:100857. doi: 10.1016/j.lana.2024.100857

Correction to “Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study” – The Lancet Regional Health – Americas 2024; 36: 100815

Stephen DS McCarthy a, Jennifer Xiao a, Michael Pugliese b, Laurent Perrault-Sequeira c, Daniel T Myran b,d,e,
PMCID: PMC11345921  PMID: 39188967

This is to correct Table 3 in the published work. We apologise for any inconvenience the error may have caused.

Corrected Table 3.

Subgroup mean monthly rate of anxiety disorder + cannabis ED visits per 1000 anxiety disorder ED visits.

graphic file with name fx1.gif

Medical cannabis legalization (period 1) is compared with cannabis commercialization/COVID-19 (period 4). The other policy periods are in Table S2.

Abbreviations: ED, emergency department.

aRisk Ratio adjusted for season.

bP-value is the interaction between the exposure and the subgroup.


Articles from Lancet Regional Health - Americas are provided here courtesy of Elsevier

RESOURCES